Evaluation of neutralization patterns of the five unique Argentine equine arteritis virus field strains reported.

The study investigates the neutralization patterns of five unique Argentine equine arteritis virus strains. It compares them with the reference strain, focusing on the influence of two viral proteins on infection and neutralization characteristics.

Understanding Virus Strains and Neutralization

• Equine viral arteritis (EVA) is a contagious condition, causing mild or subclinical infections in horses. Despite the existence of a single EAV serotype, it has been observed to vary in its antigenicity, pathogenicity, and ability to be neutralized by antibodies.
• The study aims to assess the neutralization attributes of the five unique EAV strains found in Argentina, by comparing them to the EAV-UCD reference strain. Attention is specifically paid to the role of the GP5 and M proteins in the interaction.

Study Expectations and Findings

• Changes in amino acids in the GP5 sequences are believed to affect their neutralizing phenotype, beyond the effects of other viral proteins. Therefore, any differences in the neutralizing phenotype amongst the Argentine strains would likely be due to variations in the GP5 and M proteins.
• The Argentine strains showed a similar neutralization pattern among themselves when a serum derived from EAV seropositive horses was used in the analysis. However, these strains showed low titers when the assay was done with equine polyclonal anti-EAV reference sera.

Specific Observations

• There were largely similar amino acid substitutions observed among the Argentine strains, with an exception for the LP01 strain. This particularly affected the first variable region V1, specifically in neutralization sites B and C.
• The Argentine strains displayed noticeable differences from the EAV-UCD strain. Despite this, the nucleotide and amino acid differences among the Argentine strains (LP02/R, LP02/C, LP02/P, and LP-LT-ARG) did not cause any variations in the neutralization phenotype.

Conclusion

• The study provides important insights into the ways in which variations in the EAV strains can impact their neutralization patterns, with particular attention on the role of the GP5 and M proteins. This has potential implications for preventing and managing EVA in horses.